HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new proteasome inhibitor, TP-110, induces apoptosis in human prostate cancer PC-3 cells.

Abstract
Proteasome inhibitors are useful in the treatment of cancer. Recently, we found a new proteasome inhibitor, TP-110, derived from tyropeptin A produced by Kitasatospora sp. Here we report that TP-110 induces apoptosis in human prostate cancer PC-3 cells. TP-110 showed strong cytotoxicity to PC-3 cells (IC(50)=0.05 muM). It increased the number of cells in the G(2)-M phase and increased the accumulated amounts of the p21 and p27 proteins, which are negative regulators of cell cycle progression. Furthermore, it induced apoptosis along with chromatin condensation and DNA fragmentation in PC-3 cells, and TP-110-induced apoptosis appeared to be associated with caspase activation. Additionally, TP-110 inhibited not only the degradation of IkappaB and the nuclear translocation of nuclear factor-kappaB (NF-kappaB), but also the DNA binding activity of NF-kappaB. These results indicate that TP-110 shows a strong growth inhibition and apoptosis in PC-3 cells.
AuthorsIsao Momose, Masatomi Iijima, Manabu Kawada, Daishiro Ikeda
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 71 Issue 4 Pg. 1036-43 (Apr 2007) ISSN: 0916-8451 [Print] England
PMID17420589 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 1-naphthylacetyl-(O-methyl)-tyrosyl-valyl-(O-methyl)-tyrosinal
  • Antibiotics, Antineoplastic
  • Benzimidazoles
  • Fluorescent Dyes
  • NF-kappa B
  • Oligopeptides
  • Proteasome Inhibitors
  • bisbenzimide ethoxide trihydrochloride
Topics
  • Antibiotics, Antineoplastic (pharmacology)
  • Apoptosis (drug effects)
  • Benzimidazoles
  • Blotting, Western
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • DNA Fragmentation (drug effects)
  • Fluorescent Dyes
  • Humans
  • Male
  • NF-kappa B (biosynthesis, genetics)
  • Oligopeptides (pharmacology)
  • Prostatic Neoplasms (drug therapy)
  • Proteasome Inhibitors
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: